Fund HoldingsTri Locum Partners LP

Total Portfolio Value
$417.41M
Total Bought
$182.54M
Total Sold
$162.04M
Net Transaction
+$20.50M
Filing Period:
Securities
SharesValue ($K)
Q2 2024
Q3 2024
Change
Q2 2024
Q3 2024
Weight (%)
Change
PFIZER INC(PFE)596,9191,732,935+1,136,01616,70250,15112.01%+33,449
STEVANATO GROUP S P A
ORD SHS
565,4221,867,938+1,302,51610,37037,3598.95%+26,989
VAXCYTE INC(PCVX)113,344271,922+158,5788,55931,0737.44%+22,514
AVADEL PHARMACEUTICALS PLC01,660,955+1,660,955021,7835.22%+21,783
VERONA PHARMA PLC0593,980+593,980017,0894.09%+17,089
NATERA INC(NTRA)230,585317,439+86,85424,97040,2999.65%+15,329
INSPIRE MED SYS INC(INSP)133,276151,429+18,15317,83631,9597.66%+14,123
BIOHAVEN LTD(BHVN)0193,195+193,19509,6542.31%+9,654
TEVA PHARMACEUTICAL INDS LTD(TEVA)2,550,3072,755,737+205,43041,44249,65811.90%+8,216
MIND MEDICINE MINDMED INC382,0551,662,953+1,280,8982,7559,4622.27%+6,708
UNITED THERAPEUTICS CORP DEL(UTHR)50,10054,926+4,82615,95919,6834.72%+3,723
LEGEND BIOTECH CORP(LEGN)356,532362,270+5,73815,79117,6534.23%+1,863
ARGENX SE(ARGX)74,55862,474-12,08432,06333,8668.11%+1,803
FEMASYS INC30,60630,606035340.01%-1
KORRO BIO INC71,42864,014-7,4142,4192,1390.51%-280
NOVO-NORDISK A S(NVO)63,81167,257+3,4469,1088,0081.92%-1,100
PRAXIS PRECISION MEDICINES I(PRAX)75,3190-75,3193,1150-3,115
OCULAR THERAPEUTIX INC(OCUL)514,6420-514,6423,5200-3,520
XENON PHARMACEUTICALS INC(XENE)101,9590-101,9593,9750-3,975
MADRIGAL PHARMACEUTICALS INC(MDGL)65,35243,287-22,06518,3099,1862.20%-9,123
MERUS N V335,514192,157-143,35719,8529,6002.30%-10,252
INSMED INC(INSM)316,501143,920-172,58121,20610,5062.52%-10,699
ALNYLAM PHARMACEUTICALS INC(ALNY)45,0000-45,00010,9350-10,935
AXSOME THERAPEUTICS INC(AXSM)306,51391,721-214,79224,6748,2431.97%-16,431
AVADEL PHARMACEUTICALS PLC1,189,5180-1,189,51816,7250-16,725
REGENERON PHARMACEUTICALS(REGN)17,5160-17,51618,4100-18,410
AMGEN INC(AMGN)82,2710-82,27125,7060-25,706
ASCENDIS PHARMA A/S(ASND)227,7620-227,76231,0620-31,062
Page 1 of 1